A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

Clinical trial NCT05080959 · COMPLETED

Trial details

NCT number: NCT05080959
Sponsor: Cali Pharmaceuticals LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Inguinal Herniorrhaphy

Start date: 2021-07-28
Primary completion: 2021-12-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.